A randomized trial comparing plasma drug concentrations and efficacies between 2 nonnucleoside reverse-transcriptase inhibitor-based regimens in HIV-infected patients receiving rifampicin: the N2R Study.
W. Manosuthi, S. Sungkanuparph, P. Tantanathip, A. Lueangniyomkul +8 more

